Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modelling.

Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modelling.
复制标题

DOI:
10.5588/ijtld.13.0851
复制
发表时间:
2014-09
期刊:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
影响因子:
--
通讯作者:
TB MAC meeting participants
TB MAC meeting participants
中科院分区:
其他
文献类型:
--
作者:
Dowdy DW;Houben R;Cohen T;Pai M;Cobelens F;Vassall A;Menzies NA;Gomez GB;Langley I;Squire SB;White R;TB MAC meeting participants

文献摘要

参考文献

被引文献

相似文献

结核病诊断检测的格局正在迅速变化,利益攸关方迫切需要指导如何以最大限度地发挥影响和最佳利用现有资源的方式开发、部署和优化结核病诊断。当必须在只有不完整或初步数据的情况下作出决定时,建模是提供这种指导的有用工具。在结核病建模和分析联盟组织的建模者和其他主要利益相关者会议之后,我们提出了一个定位结核病诊断模型的概念框架。我们使用该框架描述了四个关键领域的建模优先级:Xpert® MTB/RIF规模扩大,新型检测的目标产品特征,支持新药方案的药物敏感性测试,以及未来TB诊断模型的改进。如果我们要最大限度地提高结核病诊断的影响和成本效益,这些建模优先事项应作为未来研究的目标。
The landscape of diagnostic testing for tuberculosis (TB) is changing rapidly, and stakeholders need urgent guidance on how to develop, deploy and optimize TB diagnostics in a way that maximizes impact and makes best use of available resources. When decisions must be made with only incomplete or preliminary data available, modelling is a useful tool for providing such guidance. Following a meeting of modelers and other key stakeholders organized by the TB Modelling and Analysis Consortium, we propose a conceptual framework for positioning models of TB diagnostics. We use that framework to describe modelling priorities in four key areas: Xpert® MTB/RIF scale-up, target product profiles for novel assays, drug susceptibility testing to support new drug regimens, and the improvement of future TB diagnostic models. If we are to maximize the impact and cost-effectiveness of TB diagnostics, these modelling priorities should figure prominently as targets for future research.
结核病诊断的进展:XPERT MTB/RIF分析和未来的预期测试。
DOI: 10.1016/s1473-3099(13)70008-2
发表时间: 2013-04
期刊: The Lancet. Infectious diseases
影响因子: --
作者:
Lawn SD;Mwaba P;Bates M;Piatek A;Alexander H;Marais BJ;Cuevas LE;McHugh TD;Zijenah L;Kapata N;Abubakar I;McNerney R;Hoelscher M;Memish ZA;Migliori GB;Kim P;Maeurer M;Schito M;Zumla A
通讯作者: Zumla A
DOI: 10.1183/09031936.00193413
发表时间: 2014-06
期刊: The European respiratory journal
影响因子: --
作者:
Tanimura T;Jaramillo E;Weil D;Raviglione M;Lönnroth K
通讯作者: Lönnroth K
DOI: 10.1186/1471-2458-12-980
发表时间: 2012-11-14
期刊: BMC public health
影响因子: 4.5
作者:
Barter DM;Agboola SO;Murray MB;Bärnighausen T
通讯作者: Bärnighausen T
DOI: 10.1586/17476348.3.1.67
发表时间: 2009-02-01
影响因子: 3.9
作者:
Cohen, Ted;Dye, Christopher;Murray, Megan
通讯作者: Murray, Megan
DOI: 10.5588/ijtld.12.0573
发表时间: 2013-07
期刊: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
影响因子: --
作者:
Dowdy DW;Dye C;Cohen T
通讯作者: Cohen T